Nuo Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $548.9K | $283.7K | $928.7K | $2.1M | $1.4M | $161.4K | $20.3K | $636.9K |
| Accounts Receivable | $561.7K | $248.2K | $250.7K | $92.3K | $0 | — | — | — |
| Inventory | $213.8K | $150.4K | $209.6K | $240.0K | $0 | — | — | $25.3K |
| Total Current Assets | $1.4M | $841.5K | $1.6M | $2.6M | $1.5M | $161.4K | $276.5K | $866.7K |
| Property, Plant & Equipment | $366.3K | $177.0K | $45.1K | $53.2K | $0 | $0 | $0 | $105.5K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.8M | $1.2M | $1.9M | $3.0M | $1.5M | $161.4K | $276.5K | $975.5K |
| Liabilities | ||||||||
| Accounts Payable | $436.1K | $219.2K | $394.5K | $397.7K | $526.6K | $518.4K | $538.7K | $437.3K |
| Total Current Liabilities | $1.3M | $578.5K | $674.5K | $600.4K | $673.1K | $665.0K | $1.5M | $1.1M |
| Long-Term Debt | — | — | — | — | $0 | — | — | — |
| Total Liabilities | $2.8M | $675.8K | $838.7K | $856.0K | $673.1K | $665.0K | $1.5M | $1.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-34.8M | $-32.3M | $-29.9M | $-26.8M | $-23.6M | $-23.5M | $-23.4M | $-22.2M |
| Total Stockholders' Equity | $-956.6K | $513.7K | $1.0M | $2.2M | $792.8K | $-503.5K | $-1.2M | $-82.0K |